AUDEARA LIMITED — AGM Information 2021

Nov 18, 2021

Annual General Meeting AGM PRESENTATION NN o vember 2021vember 2021

Managing Director AGM Presentation AGM PRESENTATION November 2021November 2021

Disclaimer

FORWARD LOOKING STATEMENTS

Audeara Limited (Audeara) makes no representation or warranty, either express or implied, in relation to the accuracy or completeness of the information contained within this ASX Presentation.

Statements and material contained in this ASX Presentation, particularly those regarding possible or assumed future performance or potential growth of Audeara, industry growth or other trend projections are, or may be, forward looking statements. Such statements relate to future events and expectations and are based on current expectations and beliefs. Such forward looking statements are not guarantees of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are outside the control of Audeara.

Graphs used in this ASX Presentation (including data used in the graphs) are sourced from third parties and Audeara has not independently verified the information. Although reasonable care has been taken to ensure that the facts stated in this ASX Presentation are accurate and or that the opinions expressed are fair and reasonable, no reliance can be placed for any purpose whatsoever on the information contained in this document or on its completeness. Actual results and developments may differ materially from those expressed or implied by these forward-looking statements depending on a variety of factors.

Nothing in this ASX Presentation should be construed as either an offer to sell or a solicitation of an offer to buy or sell shares in any jurisdiction.

==> picture [19 x 16] intentionally omitted <==

AUSTRALIAN CLINICS STOCKING AUDEARA – LEAD INDICATOR

==> picture [536 x 327] intentionally omitted <==

● November 2021, Audeara has over 800 Audiology Clinics stocking A-01

Actively pursuing commercial relationships with other large audiology clinic groups, which includes Audika and Specsavers, which offer the potential to materially grow the number of Australian audiology clinics stocking Audeara

Currently selling through:

==> picture [76 x 60] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [75 x 35] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [76 x 60] intentionally omitted <==

==> picture [19 x 16] intentionally omitted <==

AUSTRALIAN SALES

- CLINICS AND RETAIL

==> picture [542 x 323] intentionally omitted <==

----- Start of picture text -----

IPO
----- End of picture text -----

Strong sales growth driven by:

• Increasing number of clinics holding and selling stock

• Increasing volume sold by each clinic

• Becoming only headphone stocked in Amplifon Australia

• Increased focus on NDIS, attending key events and aligning with quality NDIS marketplaces

==> picture [19 x 16] intentionally omitted <==

1. These figures are unaudited management prepared accounts for the purpose of discussing Audeara’s customer mix in Australia Calendar year quarters

US CLINIC GROWTH INITIATIVES

• Winner of the Hearing Health Matters Innovation Award at American Audiology Association Conference in Portland, Oregon – October 2021

• Primary sales focus remains on building relationships with key buying groups (who represent independent clinic groups)

• Receiving positive feedback from first units shipped to clinics

• In advanced conversations to launch initial test clinics

• First 500 A-01 TV Bundles shipped to US distributor to support sales initiatives

• Continuing to build our US sales capabilities

• Managing Director James Fielding relocating to USA for Q1 2022 to drive US growth

==> picture [125 x 58] intentionally omitted <==

==> picture [52 x 52] intentionally omitted <==

==> picture [135 x 144] intentionally omitted <==

==> picture [19 x 16] intentionally omitted <==

TECHNICAL UPDATE

• The next generation of Audeara’s headphone products, the A-02s have completed preproduction and are undergoing device certification.

• Audeara has committed to the first mass production run and expect the A-02 to be commercially available in Q1 2022.

• The A-02 features are designed to improve device usability and simplify the initial setup.

• Desktop software; AudAssist will be released shortly, allowing audiologists and clinicians to personalise the headphones with a client’s existing audiogram. The mobile version of AudAssist has been successfully trialed and the team is confident a desktop version will be more widely adopted.

• Chip supply chain made more secure by advanced purchase of high quantities of required chipsets and translation of technology away from low availability chipsets

==> picture [231 x 162] intentionally omitted <==

==> picture [129 x 58] intentionally omitted <==

==> picture [19 x 16] intentionally omitted <==

Image for illustration purposes only

Thank you